We investigate the light-curve properties of a sample of 26 spectroscopically confirmed hydrogen-poor superluminous supernovae (SLSNe-I) in the Palomar Transient Factory survey. These events are ...brighter than SNe Ib/c and SNe Ic-BL, on average, by about 4 and 2 mag, respectively. The peak absolute magnitudes of SLSNe-I in rest-frame g band span −22 Mg −20 mag, and these peaks are not powered by radioactive 56Ni, unless strong asymmetries are at play. The rise timescales are longer for SLSNe than for normal SNe Ib/c, by roughly 10 days, for events with similar decay times. Thus, SLSNe-I can be considered as a separate population based on photometric properties. After peak, SLSNe-I decay with a wide range of slopes, with no obvious gap between rapidly declining and slowly declining events. The latter events show more irregularities (bumps) in the light curves at all times. At late times, the SLSN-I light curves slow down and cluster around the 56Co radioactive decay rate. Powering the late-time light curves with radioactive decay would require between 1 and 10 M of Ni masses. Alternatively, a simple magnetar model can reasonably fit the majority of SLSNe-I light curves, with four exceptions, and can mimic the radioactive decay of 56Co, up to ∼400 days from explosion. The resulting spin values do not correlate with the host-galaxy metallicities. Finally, the analysis of our sample cannot strengthen the case for using SLSNe-I for cosmology.
Pregnancy rate following one cycle of IVF and ET can be as high as 60%. But even in the very successful units, some couples fail repeatedly. The causes for repeated implantation failure (RIF) may be ...because of reduced endometrial receptivity, embryonic defects or multifactorial causes. Various uterine pathologies, such as thin endometrium, altered expression of adhesive molecules and immunological factors, may decrease endometrial receptivity, whereas genetic abnormalities of the male or female, sperm defects, embryonic aneuploidy or zona hardening are among the embryonic reasons for failure of implantation. Endometriosis and hydrosalpinges may adversely influence both. In this mini review, we discuss the suggested methods for evaluation and treatment of RIF: repeated hysteroscopy, myomectomy, endometrial stimulation, immunotherapy, preimplantation genetic screening (PGS), assisted hatching, zygote intra-Fallopian transfer (ZIFT), co-culture, blastocyst transfer, cytoplasmic transfer, tailoring stimulation protocols and salpingectomy for hydrosalpinges.
Phytochemicals exert antiviral activity and may play a potential therapeutic role in hepatitis C virus (HCV) infection. In this work, we aimed to isolate NS3 inhibitors from traditional Indian ...medicinal plants that were found, in our earlier study, to inhibit HCV NS3 protease activity and to evaluate their potential to inhibit HCV replication. A potent inhibitory effect of NS3 catalytic activity was obtained with Embelia ribes plant extracts. Quercetin, a ubiquitous plant flavonoid, was identified as the active substance in the fractioned extract. It was found to inhibit NS3 activity in a specific dose‐dependent manner in an in vitro catalysis assay. Quercetin inhibited HCV RNA replication as analysed in the subgenomic HCV RNA replicon system. It also inhibited HCV infectious virus production in the HCV infectious cell culture system (HCVcc), as analysed by the focus‐forming unit reduction assay and HCV RNA real‐time PCR. The inhibitory effect of quercetin was also obtained when using a model system in which NS3 engineered substrates were introduced in NS3‐expressing cells, providing evidence that inhibition in vivo could be directed to the NS3 and do not involve other HCV proteins. Our work demonstrates that quercetin has a direct inhibitory effect on the HCV NS3 protease. These results point to the potential of quercetin as a natural nontoxic anti‐HCV agent reducing viral production by inhibiting both NS3 and heat shock proteins essential for HCV replication.
Herein we report the synthesis and investigation of the properties of two tris-cyclometalated luminescent iridium complexes. These complexes are the simple derivatives of fac-Ir(ppy)
bearing amino ...alkyl groups on one of the phenylpyridine rings. The complexes are highly emissive and exhibit structured emission peaks in aqueous solution while having only broad unstructured emission in organic solvents. The complexes have been shown to be taken up by NIH-3T3 and PC3 cells, where they localize in the lysosomes and remain emissive with lifetimes in the microsecond domain.
Display omitted
•Limited elimination of compounds such as tramadol, and venlafaxine by classical biodegradation.•Ability of aquatic plants to remove psychoactive pharmaceuticals from wastewater.•High ...methamphetamine accumulation in Pistia stratiotes, high tramadol accumulation in Cabomba caroliniana.
Since WWTPs are not able to eliminate all psychoactive pharmaceuticals, these compounds become a part of the aquatic ecosystem. Our results indicate that compounds such as codeine or citalopram are eliminated with low efficiency (<38%), and compounds such as venlafaxine, oxazepam, or tramadol even with almost no efficiency. Lower elimination efficiency may be caused by the accumulation of these compounds in the wastewater treatment process. This study is focused on the possibility to remove problematic psychoactive compounds using aquatic plants. HPLC-MS analysis of the leaf extract obtained from studied plants showed that the amount of accumulated methamphetamine was highest in Pistia stratiotes and lower in the leaves of Limnophila sessiliflora and Cabomba caroliniana. However, tramadol and venlafaxine were accumulated considerably only in Cabomba caroliniana. Our study demonstrates that especially these three compounds – tramadol, venlafaxine, and methamphetamine, are accumulated in aquatic plants and can be removed from the aquatic environment. In our study was also observed that helophytic aquatic plants show a higher ability to remove psychoactive compounds from wastewater. Iris pseudacorus showed the best results in selected pharmaceuticals removal with no bioaccumulation effect in leaves or roots.
Abstract Objectives Traditionally, pain is divided into two main groups: nociceptive pain due to an excess of nociception and neuropathic pain associated with an injury or dysfunction of the central ...or peripheral nervous system. The French neuropathic pain group has developed a specific questionnaire, the DN4, to help clinicians in the differential diagnosis of neuropathic and non-neuropathic pain. In order to allow this questionnaire to be used in international studies, it has been translated and linguistically validated into Dutch, German, Greek and Hungarian, using a well-established procedure. Methods The same method was used for each country and involved four stages: (1) two forward translations followed by comparison and reconciliation of the translations, (2) one backward translation, (3) review by an expert clinician, and (4) cognitive testing of the first seven items on patients. Results The translation work produced three types of situations. Either the original wording could be translated literally or semantic issues were discussed as the original wording was not always sufficiently clear and had to be clarified by adding an explanation, or, in the case of idiomatic phrases such as “pins and needles”, it was necessary to use different expressions, the challenge being to retain the original concept while doing so. The versions proposed to patients and experts were well understood. Conclusion The DN4 items were linguistically validated in each of the target languages, thus providing the means for standardising the diagnosis of neuropathic pain and pooling the data collected during clinical research in the different countries involved.
•COVID-19 vaccine hesitancy is growing over time.•Vaccinated caregivers, with higher education, worried their child had COVID-19 are most likely to express interest in vaccinating their child.•Having ...a primary care provider but not relying on their advice is associated with not vaccinating children.
To document the level of vaccine hesitancy in caregivers’ of children younger than 12 years of age over the course of the pandemic in Pediatric Emergency Departments (ED).
Study design
Ongoing multicenter, cross-sectional survey of caregivers presenting to 19 pediatric EDs in the USA, Canada, Israel, and Switzerland during first months of the pandemic (phase1), when vaccines were approved for adults (phase2) and most recently when vaccines were approved for children (phase3).
Willingness to vaccinate rate declined over the study period (59.7%, 56.1% and 52.1% in the three phases). Caregivers who are fully vaccinated, who have higher education, and those worried their child had COVID-19 upon arrival to the ED, were more likely to plan to vaccinate in all three phases. Mothers were less likely to vaccinate early in the pandemic, but this hesitancy attenuated in later phases. Older caregivers were more willing to vaccinate, and caregivers of older children were less likely to vaccinate their children in phase 3. During the last phase, willingness to vaccinate was lowest in those who had a primary care provider but did not rely on their advice for medical decisions (34%). Those with no primary care provider and those who do and rely on their medical advice, had similar rates of willingness to vaccinate (55.1% and 52.1%, respectively).
COVID-19 vaccine hesitancy is widespread and growing over time, and public health measures should further try to leverage identified factors associated with hesitancy in order to enhance vaccination rates among children.
What are the reproductive choices and retrospective reflections of women at least 4 years after planned oocyte cryopreservation (POC)?
This was an internet survey, using the REDCap application, of ...women who underwent POC, at a single-centre university-affiliated IVF unit, 4–8 years before the survey. The questionnaire addressed reproductive choices and outcomes following POC.
Seventy-nine women who underwent POC during 2011–2014 were invited to participate, and 70 (89%) responded. Mean age at cryopreservation was 37.1 ± 2.4 (range 30–41) years, mean age at study participation 42.6 ± 2.6 (range 35–48) years, and mean time from first cryopreservation cycle to study participation 5.5 ± 1.3 (range 4–8) years. The main retrospectively reported reason for POC was not wanting to become pregnant without a partner (59, 84%). During the follow-up period, 44 women (63%) attempted to conceive either naturally or by assisted reproductive technology using fresh or cryopreserved oocytes. Of those, 28 women achieved a live birth (64% of those who tried to conceive). Fourteen respondents (20% of all respondents) reported using their cryopreserved oocytes, and three (21%) achieved a birth using those oocytes. Fifteen women (34%) of those who tried to conceive used donor spermatozoa.
The most common reasons for not using frozen oocytes were achieving pregnancy without frozen oocytes or preferring not to have a child without a partner. A considerable proportion of women who had POC and were not interested in being a single parent by choice eventually try to conceive using donor spermatozoa several years later.